Risk Flags
6- QB Instability
New Orleans has an uncertain QB situation heading into 2025-2026 with potential changes incoming. Olave's elite production is heavily dependent on QB play, and Saints' QB volatility directly impacts his target volume and efficiency.
- Pulmonary Blood Clot
A blood clot was found in the wide receiver's lung, requiring him to miss Week 18. While not expected to have a long-term impact at this time, this adds a new health dimension requiring ongoing monitoring.
- Medical History
Olave was hospitalized with a pulmonary embolism (blood clot in lung) in Week 18 of 2025. Though expected to make a full recovery and rejoin offseason activities by April 2026, this is a serious cardiac event that directly complicates his contract extension negotiations and creates legitimate long-term health uncertainty.
- QB Dependency
The Saints are preparing to move ahead with Tyler Shough as their starting QB in 2026, who went 5-4 as starter after taking over for Spencer Rattler in November. While Shough showed promise late-season, rookie QB volatility and potential sophomore slump would eviscerate the Saints' momentum.
- Contract Situation
Olave is on his 5th-year option ($15.49M for 2026) with extension talks ongoing but stalled — Saints are reportedly unwilling to exceed $30M/year due to concerns about his combined concussion history and blood clot. A prolonged stalemate increases trade request or holdout risk entering 2026 camp.
- Draft Capital
The Saints invested the #8 overall pick in Jordyn Tyson (6'2", Arizona State), a blue-chip WR complement, plus Bryce Lance (R4) and Barion Brown (R6). Near-term framing from the Saints organization paints Tyson as a complement who draws coverage away from Olave, but a top-10 WR will inevitably absorb targets as he develops — the volume ceiling compression risk is real over a 1-2 year horizon.